| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698304 | Clinical Oncology | 2016 | 8 Pages |
Abstract
The presence of residual tumour at repeat craniotomy within 6 months of radiotherapy is not an independent indicator of prognosis. Patients with residual tumour that had a low Ki67 had a similar median survival as those with only treatment necrosis. Reduced proliferation of residual tumour cells and widespread necrosis may be more important indicators for future outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
C. Gzell, H. Wheeler, D. Huang, P. Gaur, J. Chen, M. Kastelan, M. Back,